Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cognitive Impact of Neoadjuvant Chemotherapy for Ovarian Cancer

NCT07125209 is registered in ClinicalTrials.gov with University of Wisconsin, Madison as lead sponsor.

NCT NCT07125209
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07125209 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cognitive Impact of Neoadjuvant Chemotherapy for Ovarian Cancer
Lead sponsor
University of Wisconsin, Madison
Phase
Observational
Overall status
Recruiting
Start date
April 28, 2026
Completion date
December 31, 2027
Enrollment
18 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cognitive change, ovarian cancer